MDS: Clinical Trials

10 trials for MDS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 unknown. 10 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Unknown 10
Phase 12Unknown 2
Phase 32Unknown 2

Follow MDS: new trials by email Literature Review of MDS trials Research Report on MDS

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Venetoclax Plus RIC Regimen Allo-HSCT for Elderly Patients With High-risk Myeloid Malignancies
Venetoclax plus RIC - Leukemia, Myeloid, Acute, MDS
Phase 2UnknownXianmin Song, MD502022-11-012023-11-28
Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS
BST-236 - AML, Adult, MDS
Phase 2UnknownBioSight Ltd.402021-11-142023-03-09
Hetrombopag for Low/Intermediate-1 Risk MDS With Thrombocytopenia
Hetrombopag, Stanozolol Tablets - MDS
Phase 2 / Phase 3UnknownPeking Union Medical College Hospital502021-10-012021-09-24
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
Azacitidine, all trans retinoic acid - AML, MDS
Phase 2 / Phase 3UnknownThe First Affiliated Hospital of Soochow University1802021-05-012022-01-03
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
APG-115, 5-azacitidine - AML, Acute Myeloid Leukemia
Phase 1 / Phase 2UnknownAscentage Pharma Group Inc.692020-12-042024-02-01
Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT
Chidamide, Cyclophosphamide, cyclosporine A - Leukemia, Acute, MDS
Phase 2UnknownSichuan University502019-01-012018-07-18
A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS
Deferasirox, Vitamin D and Azacitidine - MDS
Phase 1 / Phase 2UnknownGroupe Francophone des Myelodysplasies502013-02-012018-01-10
ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS
Clofarabine, ara-C, FLAMSA - Acute Myeloid Leukemia, MDS
Phase 2UnknownHannover Medical School602011-07-012011-08-29
Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes
Azacitidine, Azacitidine associated with Valproic acid, Azacitidine associated with Lenalidomide - MDS
Phase 2UnknownAssistance Publique - Hôpitaux de Paris3202011-06-012019-02-19
Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)
fludarabine phosphate, busulfan - AML, MDS
Phase 2UnknownSamsung Medical Center1142008-08-012008-12-30

Narrower conditions

Leukemia, Myeloid, Acute (5)  ·  Myelodysplastic Syndromes (2)  ·  Frailty (1)  ·  Hematologic Neoplasms (1)  ·  Leukemia (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Lymphoma (1)  ·  Recurrence (1)

Broader conditions

Hemic and Lymphatic Diseases (7)  ·  Neoplasms (7)  ·  Neoplasms by Histologic Type (7)  ·  Hematologic Diseases (6)  ·  Leukemia (5)  ·  Leukemia, Myeloid (5)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Bone Marrow Diseases (2)  ·  Disease Attributes (2)  ·  Chronic Disease (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)

Interventions

Azacitidine (4)  ·  Busulfan (1)  ·  Clofarabine (1)  ·  Cyclophosphamide (1)  ·  Cyclosporine (1)  ·  Cytarabine (1)  ·  Deferasirox (1)  ·  HBI-8000 (1)  ·  Idarubicin (1)  ·  Lenalidomide (1)  ·  N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1)  ·  Stanozolol (1)  ·  Tretinoin (1)  ·  Valproic Acid (1)  ·  Vitamin D (1)

Sponsors

Ascentage Pharma Group Inc. (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  BioSight Ltd. (1)  ·  Groupe Francophone des Myelodysplasies (1)  ·  Hannover Medical School (1)  ·  Peking Union Medical College Hospital (1)  ·  Samsung Medical Center (1)  ·  Sichuan University (1)  ·  The First Affiliated Hospital of Soochow University (1)  ·  Xianmin Song, MD (1)

Countries

China (4)  ·  France (2)  ·  United States (2)  ·  Belgium (1)  ·  Germany (1)  ·  South Korea (1)

Top investigators

Arnold Ganser, Prof. Dr. (1)  ·  Bing Han, Docter (1)  ·  Dong Hwan Kim (1)  ·  Felipe Suarez, MD (1)  ·  Han Yue, Ph.D (1)  ·  Olivier Hermine, MD (1)  ·  Pierre Fenaux, MD (1)  ·  Pierre Fenaux, MD, PhD (1)  ·  Ting Liu, MD (1)  ·  Xianmin Song (1)  ·  Yifan Zhai, MD, PhD (1)

Results publications

PMID 27250349